Impaired mucus-bicarbonate barrier in Helicobacter pylori-infected mice
- PMID: 16614375
- DOI: 10.1152/ajpgi.00017.2006
Impaired mucus-bicarbonate barrier in Helicobacter pylori-infected mice
Abstract
To resist the harsh intrinsic milieu, several lines of defense exist in the stomach. The aim of this study was to investigate the effect of the gastric pathogen Helicobacter pylori on these mechanisms in vivo. We used FVB/N mice expressing human alpha-1,3/4-fucosyl transferase (producing Lewis b epitopes) and inoculated with H. pylori 1. Mice were anesthetized with isoflurane or Hypnorm-midazolam, the stomach was exteriorized, and the surface of the corpus mucosa was exposed. Mucus thickness was measured with micropipettes, juxtamucosal pH (pH(jm)) was measured with pH-sensitive microelectrodes, blood flow was measured with laser-Doppler flowmetry, and mRNA levels of the bicarbonate transporter SLC26A9 were quantified with real-time PCR. The increase in mucosal blood flow seen in response to luminal acid (pH 1.5) in control animals (140 +/- 9% of control) was abolished in infected mice. The firmly adherent mucus layer was significantly thinner in infected mice (31 +/- 2 microm) than in control mice (46 +/- 5 microm), and no mucus accumulation occurred in infected mice. pH(jm) decreased significantly more on exposure to luminal acid in infected mice (luminal pH 1.5, pH(jm) 2.4 +/- 0.7) than in control mice (pH(jm) 6.4 +/- 0.5). Despite reduced pH(jm), SLC26A9 mRNA expression was significantly, by increased 1.9-fold, in infected mice. The reduction in pH(jm) by infection with H. pylori might be due to a reduced firmly adherent mucus layer, increased mucus permeability to H(+), and/or inhibition of bicarbonate transport. The upregulation of SLC26A9 in H. pylori-infected epithelium might be a result of continuous inhibition of the transporter, e.g., by ammonium, a H. pylori product, which has been previously shown to inhibit SLC26A9.
Similar articles
-
The importance of mucus layers and bicarbonate transport in preservation of gastric juxtamucosal pH.Am J Physiol Gastrointest Liver Physiol. 2002 Feb;282(2):G211-9. doi: 10.1152/ajpgi.00223.2001. Am J Physiol Gastrointest Liver Physiol. 2002. PMID: 11804841
-
Stability of pH gradients in vivo across the stomach in Helicobacter pylori gastritis, dyspepsia, and health.Am J Gastroenterol. 1992 May;87(5):590-4. Am J Gastroenterol. 1992. PMID: 1595645
-
Mucus and H. pylori.J Physiol Pharmacol. 1997 Sep;48(3):297-305. J Physiol Pharmacol. 1997. PMID: 9376612 Review.
-
An in vivo model for gastric physiological and pathophysiological studies in the mouse.Acta Physiol Scand. 2005 Jun;184(2):151-9. doi: 10.1111/j.1365-201X.2005.01434.x. Acta Physiol Scand. 2005. PMID: 15916675
-
Gastroduodenal defence mechanisms.Clin Gastroenterol. 1984 May;13(2):327-54. Clin Gastroenterol. 1984. PMID: 6378442 Review.
Cited by
-
Eradication of Helicobacter pylori Infection.Curr Gastroenterol Rep. 2016 Jul;18(7):33. doi: 10.1007/s11894-016-0509-x. Curr Gastroenterol Rep. 2016. PMID: 27177639 Free PMC article. Review.
-
Acute effects of Helicobacter pylori extracts on gastric mucosal blood flow in the mouse.World J Gastroenterol. 2009 Jan 14;15(2):219-25. doi: 10.3748/wjg.15.219. World J Gastroenterol. 2009. PMID: 19132773 Free PMC article.
-
Impact of Helicobacter pylori on the healing process of the gastric barrier.World J Gastroenterol. 2016 Sep 7;22(33):7536-58. doi: 10.3748/wjg.v22.i33.7536. World J Gastroenterol. 2016. PMID: 27672275 Free PMC article.
-
Sex differences and effects of oestrogen in rat gastric mucosal defence.World J Gastroenterol. 2017 Jan 21;23(3):426-436. doi: 10.3748/wjg.v23.i3.426. World J Gastroenterol. 2017. PMID: 28210078 Free PMC article.
-
Gastric infection by Helicobacter pylori.Curr Gastroenterol Rep. 2009 Dec;11(6):455-61. doi: 10.1007/s11894-009-0070-y. Curr Gastroenterol Rep. 2009. PMID: 19903421 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical